D‑Allulose 3‑Epimerase (DAEase)
Description
D‑Allulose 3‑Epimerase (DAEase) is a specialized biocatalyst used to convert D‑fructose into D‑allulose, one of the most promising rare sugars in the global sweetener market. As consumer demand for low‑calorie, low‑glycemic sweeteners continues to rise, DAEase has become the core technology enabling clean, efficient, and scalable allulose manufacturing.
What Makes DAEase Essential for Allulose Manufacturing
DAEase enables a highly selective epimerization reaction that transforms fructose into allulose under mild, food‑grade conditions. Compared with traditional chemical processes, enzyme‑based production offers advantages in sustainability, product purity, and operational simplicity. This makes DAEase the preferred solution for companies developing natural sweeteners, functional foods, and next‑generation nutrition products.
Key Benefits of D‑Allulose 3‑Epimerase
High selectivity for fructose‑to‑allulose conversion
Clean‑label and environmentally friendly bioprocessing
Compatible with continuous and immobilized enzyme systems
Suitable for food, beverage, and nutraceutical applications
Supports large‑scale industrial production of rare sugars
These features position DAEase as a strategic ingredient for manufacturers seeking reliable, cost‑effective, and sustainable allulose production.
Applications
1. Allulose Manufacturing
DAEase is widely used in commercial allulose production lines, enabling efficient conversion of fructose‑based raw materials into high‑purity allulose suitable for global food‑grade markets.
2. Food & Beverage Innovation
Allulose produced via DAEase is used in:
Reduced‑sugar beverages
Bakery and confectionery
Sports and performance nutrition
Keto‑friendly and diabetic‑friendly products
3. Health & Wellness Products
Allulose is valued for its low caloric impact, excellent taste profile, and metabolic benefits, making DAEase a key technology for modern functional nutrition.
Why Choose Our DAEase
Our D‑Allulose 3‑Epimerase is developed for professional manufacturers seeking:
Reliable performance in industrial environments
Strong compatibility with diverse fructose substrates
Flexible integration into existing bioprocess systems
Consistent quality for food‑grade and commercial applications
We also support custom enzyme development, process optimization, and technical collaboration to help partners achieve higher efficiency and lower production costs.
Related:
SBS Genetech is recognized as one of the global major leading industry players in Synthetic Biology by third-party market researchers. For more details, please visit Outlook on the Synthetic Biology: DNA Cloning Global Market to 2035 - Industry Trends and Forecasts.
